RocRock Biotechnology

RocRock Biotechnology is a clinical-stage biopharmaceutical company based in Suzhou, China, specializing in the discovery and development of next-generation Rho-associated protein kinase (ROCK) inhibitors. The company leverages its deep expertise in ROCK biology to develop highly selective small molecule therapeutics for a range of conditions, including fibrotic diseases, autoimmune disorders, and ophthalmic conditions. Its lead programs target ROCK1 and ROCK2 isoforms to address unmet medical needs in idiopathic pulmonary fibrosis and chronic graft-versus-host disease. RocRock aims to optimize the safety and efficacy profiles of ROCK inhibitors to expand their clinical utility across multiple therapeutic areas.